Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Physiology, Cholinergic Receptors

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Physiology, Cholinergic Receptors

Adlei B. Carlson et al.
Free Books & Documents

Excerpt

Cholinergic receptors function in signal transduction of the somatic and autonomic nervous systems. The receptors are named because they become activated by the ligand acetylcholine. These receptors subdivide into nicotinic and muscarinic receptors, which are named secondary to separate activating ligands that contributed to their study. Nicotinic receptors are responsive to the agonist nicotine, while muscarinic receptors are responsive to muscarine.

The two receptors differ in function as ionotropic ligand-gated and G-protein coupled receptors, respectively. Nicotinic receptors function within the central nervous system and at the neuromuscular junction. While muscarinic receptors function in both the peripheral and central nervous systems, mediating innervation to visceral organs. The difference in signal transduction of the two receptor types confers separate physiological functions upon receptor activation. Furthermore, differences in receptor subtypes create unique implications for pharmacologic targets and pathogenesis of the disease.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Adlei Carlson declares no relevant financial relationships with ineligible companies.

Disclosure: Gregory Kraus declares no relevant financial relationships with ineligible companies.

References

    1. Sofuoglu M, Mooney M. Cholinergic functioning in stimulant addiction: implications for medications development. CNS Drugs. 2009 Nov;23(11):939-52. - PMC - PubMed
    1. Martyn JA, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology. 2006 Jan;104(1):158-69. - PubMed
    1. Papke RL. Merging old and new perspectives on nicotinic acetylcholine receptors. Biochem Pharmacol. 2014 May 01;89(1):1-11. - PMC - PubMed
    1. Kruse AC, Kobilka BK, Gautam D, Sexton PM, Christopoulos A, Wess J. Muscarinic acetylcholine receptors: novel opportunities for drug development. Nat Rev Drug Discov. 2014 Jul;13(7):549-60. - PMC - PubMed
    1. Jiang S, Li Y, Zhang C, Zhao Y, Bu G, Xu H, Zhang YW. M1 muscarinic acetylcholine receptor in Alzheimer's disease. Neurosci Bull. 2014 Apr;30(2):295-307. - PMC - PubMed

Publication types

LinkOut - more resources